FRANKFURT, Germany — Updated results released Friday highlighted the lasting benefits of a CRISPR-based medicine for blood disorders developed by Vertex Pharmaceuticals and CRISPR Therapeutics, as the ...
Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...
Morning Overview on MSN
CRISPR boosts a little-known fruit into a big farming win
Goldenberries have long been a niche curiosity, tucked into specialty produce aisles and health food shops while tomatoes and ...
Morning Overview on MSN
CRISPR researchers revived an ancient gene that could block disease
Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, ...
(RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday reported compelling long-term data for its CRISPR/Cas9 gene-edited therapy, PrCASGEVY, at the EHA Congress. In sickle cell disease trials, 95.6 ...
Researchers have identified a mechanism by which an oncogene commonly activated in cancer patients affects the growth rate of cells. In the future, the findings can help in developing new treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback